Publications

Showing

0

out of

0

results

Cognitive Impairment 13 Months After Hospitalization for COVID-19

Stavem K, Einvik G, Lundqvist C

January 6, 2022

Reasons and predictors of non-thrombolysis in patients with acute ischemic stroke admitted within 4.5 h

Bergh E, et al.

January 6, 2022

Global impact of the COVID-19 pandemic on subarachnoid haemorrhage hospitalisations, aneurysm treatment and in-hospital mortality: 1-year follow-up

SVIN COVID-19 Global SAH Registry

January 6, 2022

Association of adverse childhood experiences with the development of multiple sclerosis

Eid K, Torkildsen Ø, et al.

January 5, 2022

The Effect of Smoking on Long-term Gray Matter Atrophy and Clinical Disability in Patients with RRMS

Lie IA, Wesnes K, et al.

January 5, 2022

Serum neurofilament as a predictor of 10-year grey matter atrophy and clinical disability in multiple sclerosis: a longitudinal study

Lie IA, Kaçar S, et al.

January 5, 2022

Tenecteplase versus alteplase for the management of acute ischaemic stroke in Norway (NOR-TEST 2, part A): a phase 3, randomised, open-label, blinded endpoint, non-inferiority trial

Kvistad CE, et al.

January 5, 2022

Plasma levels of BDNF and EGF are reduced in acute stroke patients

Øverberg LT, et al.

January 5, 2022

Genetic Epidemiology of Amyotrophic Lateral Sclerosis in Norway: A 2-Year Population-Based Study

Olsen CG, Busk ØL, et al.

January 4, 2022

Global Impact of the COVID-19 Pandemic on Cerebral Venous Thrombosis and Mortality

Nguyen TN, Qureshi MM, et al.

January 4, 2022